The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation and evolving clinical practice, particularly in complex anatomies such as the ascending aorta, aortic arch, and thoracoabdominal aorta.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in Europe from 2019 to 2035.<\/p>\n
The increasing availability of aortic stent grafts for complex anatomies is driving market growth.<\/strong><\/p>\n Which aortic stent grafts are currently available in Europe, and which indications do they treat?<\/p>\n Which new aortic stent grafts are expected to enter the European market?<\/p>\n Which devices are most widely used by indication and country?<\/p>\n How will new device entry impact FEVAR<\/abbr> and BEVAR<\/abbr> procedures?<\/p>\n New devices for the ascending aorta are expected to launch.<\/strong><\/p>\n When will ascending aortic stent grafts be introduced in Europe?<\/p>\n How will these devices impact procedure volumes and adoption trends?<\/p>\n What will be the impact on open and hybrid repair in the ascending aorta?<\/p>\n How will new product entry reshape the competitive landscape?<\/p>\n Hybrid procedures are seeing rising adoption in Europe.<\/strong><\/p>\n How rapidly will hybrid approaches be adopted as more products for these procedures become available?<\/p>\n What impact will new hybrid devices have on competition?<\/p>\n Clinical evidence and guidelines will shape adoption trends.<\/strong><\/p>\n How will clinical trial results influence market adoption?<\/p>\n What impact will European clinical guidelines have on treatment patterns?<\/p>\n","protected":false},"template":"","class_list":["post-219570","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-aortic-repair-devices","medtech-therapy-area-cardiovascular","medtech-geography-europe","medtech-date-2828"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/219570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=219570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}